click below
click below
Normal Size Small Size show me how
IOS 10 Exam 2
Resistance
| Question | Answer |
|---|---|
| B-lactam resistance most relevant and clinically significant | B-lactamase production |
| All ____ organisms have a high concentrations od B-lactamase | Gram - |
| Most common forms of B-lactamase are | TEM, SHV |
| Constitutive expression | Expression of chromosome can be low or high expression |
| Inducible expression | Usually plasmid mediated (SPACE) |
| SPACE organisms | Serratia, pseudomonas, Acintobacter, Citobacter, Enterobacter |
| SPACE organisms have what enzyme that are highly resistant | ampC |
| Stable derepression | Chromosomal carried genes that control repressor genes are mutated and enzyme is always on. |
| Anaerobic resistance | B-lactamase is very common(may produce penicillinase or cephalosporinase) also Metallo-B-lactamase resistant ot carbapenems |
| Aminoglycosides | Aminoglycoside modifying enzymes, actylase can inactivate the antibiotic |
| Fluoroquinolones resistance | Chromosomal mutaion of Topo II (gyrA) and Topo IV (parC) or efflux proteins |
| Vancomycin resistance | Alterations in D-alanyl-D lactate |
| Stap aures resistance | Penicillinase is the most common and relevant, alterations in PBP, Topo IV mutations |
| Strept pneumoniae resistance | Multi resistance: Alterations in PBP (PCN) high or low resistance, Efflux proteins & ribsomal alterations for macrolidesm clindamycin, Topo IV for quinolones, Resistant gene cassette for multi classes |
| Enterococcus resistance intrinsic | B-lactams have altered PBP,and decreased permibility |
| Enterococcus acquird resistance | Further alterations in PBP,and aminoglycodises have enzyme modifications |
| Gram negative bacilli resistance | B-lactamase production most common. Permability, aminoglycoside inactivating enzymes, DNA grA mutations |